Nanoengineers at the University of California San
Diego have developed immune cell-mimicking nanoparticles that
target inflammation in the lungs and deliver drugs directly where
they’re needed. As a proof of concept, the researchers filled the
nanoparticles with the drug dexamethasone and administered them to
mice with inflamed lung tissue. Inflammation was completely treated
in mice given the nanoparticles, at a drug concentration where
standard delivery methods did not have any efficacy.
Genetically engineered nanoparticle delivers dexamethasone
directly to inflamed lungs
